Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center

被引：30
|
作者：
Borogovac, Azra [1 ]
Keruakous, Amany [1 ,2 ]
Bycko, Michelle [1 ]
Holter Chakrabarty, Jennifer [1 ]
Ibrahimi, Sami [1 ]
Khawandanah, Mohamad [1 ]
Selby, George B. [1 ]
Yuen, Carrie [1 ]
Schmidt, Sarah [1 ]
Autry, Marcus T. [1 ]
Al-Juhaishi, Taha [1 ]
Wieduwilt, Matthew J. [1 ]
Asch, Adam S. [1 ]
机构：
[1] Univ Oklahoma, Hematol Oncol Sect, Dept Med, Hlth Sci Ctr, Oklahoma City, OK 73019 USA
[2] Univ Augusta, Hematol Oncol Sect, Dept Med, Augusta, GA USA
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / 06期
关键词：
D O I：
10.1038/s41409-022-01664-z
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
下载
收藏
页码：1025 / 1027
页数：3
相关论文
共 50 条
  • [21] Chimeric Antigen Receptor T-Cell Therapy
    Ogba, Ndiya
    Arwood, Nicole M.
    Bartlett, Nancy L.
    Bloom, Mara
    Brown, Patrick
    Brown, Christine
    Budde, Elizabeth Lihua
    Carlson, Robert
    Farnia, Stephanie
    Fry, Terry J.
    Garber, Morgan
    Gardner, Rebecca A.
    Gurschick, Lauren
    Kropf, Patricia
    Reitan, Jeff J.
    Sauter, Craig
    Shah, Bijal
    Shpall, Elizabeth J.
    Rosen, Steven T.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (09): : 1093 - 1106
  • [22] Chimeric Antigen Receptor T-Cell Therapy
    Rasheed, Azgar Abdul
    Koyyala, Venkata Pradeep Babu
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (01) : 89 - 92
  • [23] Early Cytopenias and Infections Following Chimeric Antigen Receptor T-Cell Therapy: A Single Center Experience
    McGann, Mary
    Velayati, Arash
    Roubal, Kiera
    Granger, Katelynn
    Hashmi, Hamza
    BLOOD, 2022, 140 : 12764 - 12765
  • [24] Safety and Cost Effectiveness of Chimeric Antigen Receptor T Cell Therapy in the Outpatient Setting
    Shahzad, Moazzam
    Faisal, Muhammad Salman
    Shippey, Ernie
    Hussain, Ali
    Divine, Clint
    Mahmoudjafari, Zahra
    Appenfeller, Allison
    Mushtaq, Muhammad Umair
    Shune, Leyla
    McGuirk, Joseph P.
    Ahmed, Nausheen
    BLOOD, 2021, 138
  • [25] Development of chimeric antigen receptor (CAR) T-cell immunotherapy
    Borchmann, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 27 - 27
  • [26] Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T)
    Brown, Kevin
    Seftel, Matthew D.
    Hay, Kevin A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (33) : E1300 - E1302
  • [27] Patterns of Failure Following Chimeric Antigen Receptor T-cell (CAR-T) Therapy
    Figura, N. B.
    Jain, M. D.
    Sim, A. J.
    Chavez, J. C.
    Shah, B. D.
    Khimani, F.
    Lazaryan, A.
    Liu, H. D.
    Kim, S.
    Locke, F. L.
    Robinson, T. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S66 - S67
  • [28] Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
    Kampouri, Eleftheria
    Little, Jessica S.
    Rejeski, Kai
    Manuel, Oriol
    Hammond, Sarah P.
    Hill, Joshua A.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [29] Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Salinas, Ryan D.
    Durgin, Joseph S.
    O'Rourke, Donald M.
    CNS DRUGS, 2020, 34 (02) : 127 - 145
  • [30] GEOGRAPHIC TRENDS IN CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY ACCESS AND UTILIZATION
    McBride, K.
    Snyder, S.
    Serrano-Rubio, D.
    Gitlin, M.
    VALUE IN HEALTH, 2024, 27 (06) : S218 - S218
12345